skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

Abstract

T follicular helper (Tfh) cells are required to develop germinal center (GC) responses and drive immunoglobulin class switch, affinity maturation, and long-term B cell memory. In this study, we characterize a recently developed vaccine platform, nucleoside-modified, purified mRNA encapsulated in lipid nanoparticles (mRNA-LNPs), that induces high levels of Tfh and GC B cells. Intradermal vaccination with nucleoside-modified mRNA-LNPs encoding various viral surface antigens elicited polyfunctional, antigen-specific, CD4+T cell responses and potent neutralizing antibody responses in mice and nonhuman primates. Importantly, the strong antigen-specific Tfh cell response and high numbers of GC B cells and plasma cells were associated with long-lived and high-affinity neutralizing antibodies and durable protection. Comparative studies demonstrated that nucleoside-modified mRNA-LNP vaccines outperformed adjuvanted protein and inactivated virus vaccines and pathogen infection. The incorporation of noninflammatory, modified nucleosides in the mRNA is required for the production of large amounts of antigen and for robust immune responses.

Authors:
ORCiD logo [1];  [1];  [1]; ORCiD logo [2];  [2]; ORCiD logo [2]; ORCiD logo [2];  [3];  [1];  [1]; ORCiD logo [4];  [4];  [1];  [2]; ORCiD logo [2]; ORCiD logo [5]; ORCiD logo [2]; ORCiD logo [2]; ORCiD logo [5];  [1] more »;  [1];  [1]; ORCiD logo [1];  [1];  [6];  [6]; ORCiD logo [7]; ORCiD logo [8];  [3];  [9];  [6];  [6];  [10];  [3];  [3];  [1];  [1]; ORCiD logo [2]; ORCiD logo [1] « less
+ Show Author Affiliations
  1. Univ. of Pennsylvania, Philadelphia, PA (United States)
  2. Duke University School of Medicine, Durham, NC (United States)
  3. Univ. of Washington, Seattle, WA (United States)
  4. Duke University Medical Center, Durham, NC (United States)
  5. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  6. Acuitas Therapeutics, Vancouver, BC (Canada)
  7. Icahn School of Medicine at Mount Sinai, New York, NY (United States)
  8. BioNTech RNA Pharmaceuticals, Mainz (Germany)
  9. The Children’s Hospital of Philadelphia, Philadelphia, PA (United States)
  10. Bioqual Inc., Rockville, MD (United States)
Publication Date:
Research Org.:
Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH)
OSTI Identifier:
1505995
Report Number(s):
LA-UR-17-26175
Journal ID: ISSN 0022-1007
Grant/Contract Number:  
89233218CNA000001
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Experimental Medicine
Additional Journal Information:
Journal Volume: 215; Journal Issue: 6; Journal ID: ISSN 0022-1007
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Pardi, Norbert, Hogan, Michael J., Naradikian, Martin S., Parkhouse, Kaela, Cain, Derek W., Jones, Letitia, Moody, M. Anthony, Verkerke, Hans P., Myles, Arpita, Willis, Elinor, LaBranche, Celia C., Montefiori, David C., Lobby, Jenna L., Saunders, Kevin O., Liao, Hua-Xin, Korber, Bette T., Sutherland, Laura L., Scearce, Richard M., Hraber, Peter T., Tombácz, István, Muramatsu, Hiromi, Ni, Houping, Balikov, Daniel A., Li, Charles, Mui, Barbara L., Tam, Ying K., Krammer, Florian, Karikó, Katalin, Polacino, Patricia, Eisenlohr, Laurence C., Madden, Thomas D., Hope, Michael J., Lewis, Mark G., Lee, Kelly K., Hu, Shiu-Lok, Hensley, Scott E., Cancro, Michael P., Haynes, Barton F., and Weissman, Drew. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. United States: N. p., 2018. Web. https://doi.org/10.1084/jem.20171450.
Copy to clipboard
Pardi, Norbert, Hogan, Michael J., Naradikian, Martin S., Parkhouse, Kaela, Cain, Derek W., Jones, Letitia, Moody, M. Anthony, Verkerke, Hans P., Myles, Arpita, Willis, Elinor, LaBranche, Celia C., Montefiori, David C., Lobby, Jenna L., Saunders, Kevin O., Liao, Hua-Xin, Korber, Bette T., Sutherland, Laura L., Scearce, Richard M., Hraber, Peter T., Tombácz, István, Muramatsu, Hiromi, Ni, Houping, Balikov, Daniel A., Li, Charles, Mui, Barbara L., Tam, Ying K., Krammer, Florian, Karikó, Katalin, Polacino, Patricia, Eisenlohr, Laurence C., Madden, Thomas D., Hope, Michael J., Lewis, Mark G., Lee, Kelly K., Hu, Shiu-Lok, Hensley, Scott E., Cancro, Michael P., Haynes, Barton F., & Weissman, Drew. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. United States. https://doi.org/10.1084/jem.20171450
Copy to clipboard
Pardi, Norbert, Hogan, Michael J., Naradikian, Martin S., Parkhouse, Kaela, Cain, Derek W., Jones, Letitia, Moody, M. Anthony, Verkerke, Hans P., Myles, Arpita, Willis, Elinor, LaBranche, Celia C., Montefiori, David C., Lobby, Jenna L., Saunders, Kevin O., Liao, Hua-Xin, Korber, Bette T., Sutherland, Laura L., Scearce, Richard M., Hraber, Peter T., Tombácz, István, Muramatsu, Hiromi, Ni, Houping, Balikov, Daniel A., Li, Charles, Mui, Barbara L., Tam, Ying K., Krammer, Florian, Karikó, Katalin, Polacino, Patricia, Eisenlohr, Laurence C., Madden, Thomas D., Hope, Michael J., Lewis, Mark G., Lee, Kelly K., Hu, Shiu-Lok, Hensley, Scott E., Cancro, Michael P., Haynes, Barton F., and Weissman, Drew. Tue . "Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses". United States. https://doi.org/10.1084/jem.20171450. https://www.osti.gov/servlets/purl/1505995.
Copy to clipboard
@article{osti_1505995,
title = {Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses},
author = {Pardi, Norbert and Hogan, Michael J. and Naradikian, Martin S. and Parkhouse, Kaela and Cain, Derek W. and Jones, Letitia and Moody, M. Anthony and Verkerke, Hans P. and Myles, Arpita and Willis, Elinor and LaBranche, Celia C. and Montefiori, David C. and Lobby, Jenna L. and Saunders, Kevin O. and Liao, Hua-Xin and Korber, Bette T. and Sutherland, Laura L. and Scearce, Richard M. and Hraber, Peter T. and Tombácz, István and Muramatsu, Hiromi and Ni, Houping and Balikov, Daniel A. and Li, Charles and Mui, Barbara L. and Tam, Ying K. and Krammer, Florian and Karikó, Katalin and Polacino, Patricia and Eisenlohr, Laurence C. and Madden, Thomas D. and Hope, Michael J. and Lewis, Mark G. and Lee, Kelly K. and Hu, Shiu-Lok and Hensley, Scott E. and Cancro, Michael P. and Haynes, Barton F. and Weissman, Drew},
abstractNote = {T follicular helper (Tfh) cells are required to develop germinal center (GC) responses and drive immunoglobulin class switch, affinity maturation, and long-term B cell memory. In this study, we characterize a recently developed vaccine platform, nucleoside-modified, purified mRNA encapsulated in lipid nanoparticles (mRNA-LNPs), that induces high levels of Tfh and GC B cells. Intradermal vaccination with nucleoside-modified mRNA-LNPs encoding various viral surface antigens elicited polyfunctional, antigen-specific, CD4+T cell responses and potent neutralizing antibody responses in mice and nonhuman primates. Importantly, the strong antigen-specific Tfh cell response and high numbers of GC B cells and plasma cells were associated with long-lived and high-affinity neutralizing antibodies and durable protection. Comparative studies demonstrated that nucleoside-modified mRNA-LNP vaccines outperformed adjuvanted protein and inactivated virus vaccines and pathogen infection. The incorporation of noninflammatory, modified nucleosides in the mRNA is required for the production of large amounts of antigen and for robust immune responses.},
doi = {10.1084/jem.20171450},
journal = {Journal of Experimental Medicine},
number = 6,
volume = 215,
place = {United States},
year = {2018},
month = {5}
}
Copy to clipboard
Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1084/jem.20171450
Copyright Statement
Other availability
Search WorldCat Search WorldCat to find libraries that may hold this journal
Citation Metrics:
Cited by: 31 works
Citation information provided by
Web of Science
Save / Share:
Export Metadata
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.

Works referenced in this record:

Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells
journal, September 2009

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
journal, August 2013

  • Kwong, Peter D.; Mascola, John R.; Nabel, Gary J.
  • Nature Reviews Immunology, Vol. 13, Issue 9
  • DOI: 10.1038/nri3516

Germinal Centers
journal, April 2012

MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life
journal, April 2015

  • Mastelic Gavillet, Beatris; Eberhardt, Christiane S.; Auderset, Floriane
  • The Journal of Immunology, Vol. 194, Issue 10
  • DOI: 10.4049/jimmunol.1402071

Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
journal, June 2014

  • Fera, D.; Schmidt, A. G.; Haynes, B. F.
  • Proceedings of the National Academy of Sciences, Vol. 111, Issue 28
  • DOI: 10.1073/pnas.1409954111

Activin A programs the differentiation of human TFH cells
journal, July 2016

  • Locci, Michela; Wu, Jennifer E.; Arumemi, Fortuna
  • Nature Immunology, Vol. 17, Issue 8
  • DOI: 10.1038/ni.3494

T Follicular Helper Cell Differentiation, Function, and Roles in Disease
journal, October 2014

Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
journal, September 2011

  • Karikó, Katalin; Muramatsu, Hiromi; Ludwig, János
  • Nucleic Acids Research, Vol. 39, Issue 21
  • DOI: 10.1093/nar/gkr695

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
journal, February 2017

  • Pardi, Norbert; Hogan, Michael J.; Pelc, Rebecca S.
  • Nature, Vol. 543, Issue 7644
  • DOI: 10.1038/nature21428

Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
journal, January 2017

  • Havenar-Daughton, Colin; Lee, Jeong Hyun; Crotty, Shane
  • Immunological Reviews, Vol. 275, Issue 1
  • DOI: 10.1111/imr.12512

Quality and quantity of T FH cells are critical for broad antibody development in SHIV AD8 infection
journal, July 2015

Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
journal, December 2017

Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
journal, September 2014

Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall
journal, June 2015

An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs
journal, June 2016

Designing therapeutic cancer vaccines by mimicking viral infections
journal, April 2016

  • Sultan, Hussein; Fesenkova, Valentyna I.; Addis, Diane
  • Cancer Immunology, Immunotherapy, Vol. 66, Issue 2
  • DOI: 10.1007/s00262-016-1834-5

Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
journal, October 2016

  • Tam, Hok Hei; Melo, Mariane B.; Kang, Myungsun
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 43
  • DOI: 10.1073/pnas.1606050113

Materials for non-viral intracellular delivery of messenger RNA therapeutics
journal, October 2016

The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
journal, November 2013

Germinal Center Selection and the Antibody Response to Influenza
journal, October 2015

Toll-Like Receptor Agonist Augments Virus-Like Particle-Mediated Protection from Ebola Virus with Transient Immune Activation
journal, February 2014

Immunogenicity and protective efficacy of influenza vaccination
journal, July 2004

Synthetic DNA vaccine strategies against persistent viral infections
journal, May 2013

  • Villarreal, Daniel O.; Talbott, Kendra T.; Choo, Daniel K.
  • Expert Review of Vaccines, Vol. 12, Issue 5
  • DOI: 10.1586/erv.13.33

Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique
journal, June 2016

  • Havenar-Daughton, Colin; Reiss, Samantha M.; Carnathan, Diane G.
  • The Journal of Immunology, Vol. 197, Issue 3
  • DOI: 10.4049/jimmunol.1600320

Induction of virus-specific cytotoxic T lymphocytesin vivo by liposome-entrapped mRNA
journal, July 1993

  • Martinon, Frédéric; Krishnan, Sivadasan; Lenzen, Gerlinde
  • European Journal of Immunology, Vol. 23, Issue 7
  • DOI: 10.1002/eji.1830230749

Progress in developing virus-like particle influenza vaccines
journal, May 2016

Water-in-Oil–Only Adjuvants Selectively Promote T Follicular Helper Cell Polarization through a Type I IFN and IL-6–Dependent Pathway
journal, October 2016

  • Riteau, Nicolas; Radtke, Andrea J.; Shenderov, Kevin
  • The Journal of Immunology, Vol. 197, Issue 10
  • DOI: 10.4049/jimmunol.1600883

Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope
journal, October 2004

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
journal, May 2012

  • Montefiori, D. C.; Karnasuta, C.; Huang, Y.
  • Journal of Infectious Diseases, Vol. 206, Issue 3
  • DOI: 10.1093/infdis/jis367

mRNA vaccines — a new era in vaccinology
journal, January 2018

  • Pardi, Norbert; Hogan, Michael J.; Porter, Frederick W.
  • Nature Reviews Drug Discovery, Vol. 17, Issue 4
  • DOI: 10.1038/nrd.2017.243

Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity
journal, July 2013

  • Guo, Wenjin; Cleveland, Brad; Davenport, Thaddeus M.
  • Protein Expression and Purification, Vol. 90, Issue 1
  • DOI: 10.1016/j.pep.2013.04.009

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
journal, June 2017

Targeting Antigen to Mouse Dendritic Cells via Clec9A Induces Potent CD4 T Cell Responses Biased toward a Follicular Helper Phenotype
journal, June 2011

  • Lahoud, Mireille H.; Ahmet, Fatma; Kitsoulis, Susie
  • The Journal of Immunology, Vol. 187, Issue 2
  • DOI: 10.4049/jimmunol.1101176

A novel, disruptive vaccination technology: Self-adjuvanted RNActive
journal, October 2013

  • Kallen, Karl-Josef; Heidenreich, Regina; Schnee, Margit
  • Human Vaccines & Immunotherapeutics, Vol. 9, Issue 10
  • DOI: 10.4161/hv.25181

Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals
journal, September 2015

  • Thess, Andreas; Grund, Stefanie; Mui, Barbara L.
  • Molecular Therapy, Vol. 23, Issue 9
  • DOI: 10.1038/mt.2015.103

Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell Responses
journal, October 2015

Novel universal influenza virus vaccine approaches
journal, April 2016

Modified mRNA Vaccines Protect against Zika Virus Infection
journal, March 2017

Skin dendritic cells induce follicular helper T cells and protective humoral immune responses
journal, November 2015

  • Yao, Chen; Zurawski, Sandra M.; Jarrett, Elizabeth S.
  • Journal of Allergy and Clinical Immunology, Vol. 136, Issue 5
  • DOI: 10.1016/j.jaci.2015.04.001

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability
journal, November 2008

  • Karikó, Katalin; Muramatsu, Hiromi; Welsh, Frank A.
  • Molecular Therapy, Vol. 16, Issue 11
  • DOI: 10.1038/mt.2008.200

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
journal, July 2005

  • Morrissey, David V.; Lockridge, Jennifer A.; Shaw, Lucinda
  • Nature Biotechnology, Vol. 23, Issue 8
  • DOI: 10.1038/nbt1122

Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
journal, October 2017

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
journal, September 2012

Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins
journal, November 2009

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
journal, September 2017

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
journal, August 2013

  • Maier, Martin A.; Jayaraman, Muthusamy; Matsuda, Shigeo
  • Molecular Therapy, Vol. 21, Issue 8
  • DOI: 10.1038/mt.2013.124

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes
journal, November 2015

Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
journal, July 2012

  • Jayaraman, Muthusamy; Ansell, Steven M.; Mui, Barbara L.
  • Angewandte Chemie International Edition, Vol. 51, Issue 34
  • DOI: 10.1002/anie.201203263
    [ × clear filter / sort ]

    Works referencing / citing this record:

    mRNA as novel technology for passive immunotherapy
    journal, October 2018

    • Schlake, Thomas; Thess, Andreas; Thran, Moritz
    • Cellular and Molecular Life Sciences, Vol. 76, Issue 2
    • DOI: 10.1007/s00018-018-2935-4

    Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
    journal, September 2019

    The promise of mRNA vaccines: a biotech and industrial perspective
    journal, February 2020

    Immunological basis for enhanced immunity of nanoparticle vaccines
    journal, February 2019

    Strategies for inducing effective neutralizing antibody responses against HIV-1
    journal, November 2019

    Evaluation of a Single-Dose Nucleoside-Modified Messenger RNA Vaccine Encoding Hendra Virus-Soluble Glycoprotein Against Lethal Nipah virus Challenge in Syrian Hamsters
    journal, November 2019

    • Lo, Michael K.; Spengler, Jessica R.; Welch, Stephen R.
    • The Journal of Infectious Diseases, Vol. 221, Issue Supplement_4
    • DOI: 10.1093/infdis/jiz553

    Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes
    journal, September 2019

    Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
    journal, January 2020

    Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans
    journal, January 2019

    • Christensen, Shannon R.; Toulmin, Sushila A.; Griesman, Trevor
    • Journal of Virology, Vol. 93, Issue 8
    • DOI: 10.1128/jvi.02134-18

    Advances in mRNA Vaccines for Infectious Diseases
    journal, March 2019

      [ × clear filter / sort ]

      Similar Records in DOE PAGES and OSTI.GOV collections: